Anti-Migraine Drugs Market Research Reports and Industry Analysis


Published Date : Nov 17, 2014

In the coming years, the market for anti-migraine drugs [ http://www.marketresearchreports.biz/analysis/207524 ] is anticipated to witness several launches of new generic migraine drugs that will steadily increase the drug-treatment levels and rate of diagnosis paving a sustainable path to an annual global growth of the overall anti-migraine drugs market. 

Migraines are frequent attacks of moderate to severe headaches and anti-migraine drugs are its therapeutic curing agents. In the next five years, the cost of migraine drugs is expected to reduce due to the growing awareness of migraine and its treatment via specific anti-migraine drugs amongst individuals in the emerging countries. 

The market for anti-migraine drugs is projected for an upward growth curve mainly due to the development of new generic entrants and treatment therapies such as BOTOX and calcitonin gene-related peptides (CGRP) receptor antagonist. The market is also poised for a significant growth due to increasing incidences of migraine sufferers, increased acceptance levels, and technological advances in the development of anti-migraine drugs, thus boosting the demand for anti-migraine drugs market to grow further on a global level.

Some of the major anti-migraine drugs used to cure migraine problems include, Triptans like Sumatriptan, Zolmitriptan, and others. 

The United States is accounted to be the largest market for anti-migraine drugs as stated by a Medline article earlier. Around 12% of the U.S. population suffers from migraine headaches, which precisely pushes a number of drug companies to manufacture specific preventive medications and anti-migraine drugs that help patients relieve their intense and periodic headaches with the right treatment.  

The key market players majorly contributing to the anti-migraine drugs market include GlaxoSmithKline plc, Abbott Laboratories, Inc., Pfizer Inc., Impax, Endo Pharmaceuticals, Eli Lilly and Company, Eisai, Inc., Nautilus and Allergan, and AstraZeneca plc. 

The market research reports provided by Marketresearchreports.biz based on the anti-migraine drugs market also include a comprehensive review of micro and macro factors necessary for the existing players and new entrants, as well as covers a complete market study of recent developments in the anti-migraine drugs market.